Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07760402Recruiting
Randomised, open-label trial of propofol injection (veterinary) and sevoflurane (2 arms), sponsored by Gaziantep University. Primary endpoint: Relative expression levels of plasma microRNAs (miR-146a, miR-155, and miR-21). Started May 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07760402.